PFE Stock Price - Pfizer Inc - (PFE)
- Prev. Close: 35.36
- Open: 35.2
- Daily Range: 35.05 - 35.40
PFE NEWS FROM BIDNESS ETC
Pfizer Inc. (PFE) Q1FY15 Earnings Preview: What You Need To Know
Pfizer earnings report for the first quarter of fiscal 2015 is due for release April 28. The company is expected to report a 2.8% YoY earnings increas...
Pfizer Inc. (PFE) Stock Update: Healthy Cancer Drug Pipeline Promises Stron...
Pfizer has been performing well of late with its collaboration agreements for oncology drug development and the success of its vaccine business. The s...
Pfizer Inc. (PFE) Wins FDA Breakthrough Therapy Designation For Lung Cancer...
The designation comes on the back of positive results from an extended Phase I study on the drug
- Pfizer Inc. (PFE) And Provectus Biopharmaceuticals Get US Patent For Cancer...
- Pfizer Inc. (PFE) Victorious In First Trial Over Zoloft Birth-Defect Claims
- Mylan NV (MYL), Pfizer Inc. Reach Settlement For Viagra Patent Litigation
- Pfizer Inc. Accused Of Withholding Information On Risks Associated With Ant...
- Pfizer Inc. Partners With Merck To Co-Promote Xalkori
- Pfizer Inc. Terminates Its Collaboration With Catalyst Bio; Targacept Plung...
- BIND Therapeutics Inc And Pfizer Inc. Extend Global Accurins Collaboration
- Pfizer Shuts Down Vaccine Operations In China
- Pfizer Inc. Stops Doctors In UK From Prescribing Generic Lyrica
More News From Bidness
Pfizer Inc, Eli Lilly, AstraZeneca plc and Bristol-Myer... PUBLISHED: Mar 26, 2015 at 2:40 pm ESTPfizer Inc, Eli Lilly To Recommence Phase 3 Trials For ... PUBLISHED: Mar 24, 2015 at 11:47 am ESTPfizer Inc. (PFE) StockTo Appreciate Significantly, Say... PUBLISHED: Mar 23, 2015 at 4:27 pm ESTPfizer Inc. Publishes Prevenar 13 Data From CAPiTA Stud... PUBLISHED: Mar 19, 2015 at 12:38 pm EST
Dementia Drug Research Aided By $100 Million Venture Capital Funding PUBLISHED: Mar 16, 2015 at 8:26 am EST
Insider Selling: Pfizer Inc. (PFE), FireEye Inc (FEYE), CBS Corporation (CBS), Walt Disney Co (DIS) PUBLISHED: Mar 16, 2015 at 8:26 am EST
Bidness Etc takes a look at insider selling activity that recently took place at Pfizer, FireEye, CBS Corporation, and Walt DisneyREAD MORE
Pfizer Inc. Plans To Expand Its Vaccine Portfolio; Strategic Acquisitions May Be On The Cards PUBLISHED: Mar 13, 2015 at 9:14 am EST
Pfizer is foraying into the lucrative vaccine business by attempting to expand its portfolio from offering only one vaccine to ones that could be used to treat a variety of diseasesREAD MORE
Drug-Makers Endorse “Cap The Copay” As A New Pressure Tactic Against Insurers PUBLISHED: Mar 13, 2015 at 8:36 am EST
Patient groups funded by large drug-makers call for limits on copay from health insurers, as drug prices reach all-time highsREAD MORE
FDA Keeps Serious Warning On Pfizer Inc. Anti-Smoking Drug, Chantix PUBLISHED: Mar 10, 2015 at 7:38 am EST
FDA has declined to remove the serious warning about neuropsychiatric side-effects associated with Chantix’s usageREAD MORE
Pfizer Inc. Wins European Commission Approval For New Prevenar 13 Indication PUBLISHED: Mar 4, 2015 at 6:43 am EST
The European Commission approved an expanded indication for Pfizer’s Prevenar 13 vaccine, to prevent pneumonia in adults aged 18 years and olderREAD MORE
JP Morgan Raises EPS Estimates For Pfizer (PFE) Stock PUBLISHED: Mar 2, 2015 at 5:03 pm EST
Bidness Etc takes note of JP Morgan’s projection on Ibrance, a multi-billion dollar opportunity for PfizerREAD MORE